# Rightway Healthcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rightway-healthcare

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.rightwayhealthcare.com
- Total disclosed funding: $244M
- Latest round: Series E (Aug 25, 2026)
- Investors on record: 4

## About

Rightway Healthcare Inc. offers solutions in clinical care navigation and pharmacy benefits management. Established in 2017 and headquartered in New York, US, the company was co-founded by Jordan Feldman (CEO) and Theodore Feldman. In August 2026, Rightway Healthcare Inc. raised USD 155 million in series E funding led by Francisco Partners, with participation from Thrive Capital and Khosla Ventures.

Rightway's primary offerings center around clinical care navigation and pharmacy benefits management (PBM). Their services streamline healthcare experiences for employers and employees, providing personalized guidance and support. Rightway's health guides assist members in navigating healthcare complexities, ensuring informed decisions regarding their care options. They target a diverse client base, including employers and health systems, focusing on enhancing care quality and reducing costs. The transparent PBM model facilitates access to high-value medications and passes savings back to plan sponsors, addressing a wide range of healthcare needs across various sectors in the United States.

Rightway's revenue model is based on partnerships with employers and health systems, combining subscription-based services and fee-for-service arrangements.
Clients engage Rightway for comprehensive care navigation and PBM solutions, resulting in a transaction structure that emphasizes value-driven healthcare. Employers may pay a fixed administrative fee while benefiting from transparent pricing of pharmacy services, which includes managing prescription costs. Rightway's innovative PBM model is designed to optimize medication management and reduce overall healthcare expenditures, fostering long-term relationships with clients as they seek to enhance employee satisfaction and productivity through improved healthcare access and management. 

The company plans to use the August 2026 funding to expand its AI capabilities, transparent pharmacy benefits platform, grow its care navigation services, and help employers reduce healthcare and prescription drug costs for employees.

## Funding rounds

- Series E, Aug 25, 2026, $155M — Francisco Partners, Khosla Ventures, Thrive Capital
- Series C, Mar 30, 2021, $69M — Khosla Ventures, Tiger Global Management, Thrive Capital
- Series B, Nov 21, 2019, $20M — Thrive Capital

## Investors

- Thrive Capital (https://capitalatlas.ai/funds/thrive-capital) — Series B, Series C, Series E
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series C, Series E
- Tiger Global Management (https://capitalatlas.ai/funds/tiger-global-management) — Series C
- Francisco Partners (https://capitalatlas.ai/funds/francisco-partners) — Series E